Susan G. Komen® MBC Impact Series presents
Metastatic Breast Cancer Conference
Living and Learning: What Metastatic Breast Cancer Looks Like
Friday June 28, 2019
Hinds Community College/Clyde Muse Center
7:30 am Registration and light continental breakfast
8:00 am – 1:00 pm Conference
The Metastatic Breast Cancer Conference is designed to educate metastatic patients, breast cancer survivors, caregivers, and the general public on the ABCs of metastatic breast cancer. The first conference of it’s kind in Mississippi, this event offers information on everything from the biology and causes of metastatic tumors to how to get involved in clinical trials, complementary therapies, and everything in between.The 2019 Metastatic Conference features a keynote presentation from Komen Research Scholar Dr. Danny Welch of the University of Kansas, a panel of prestigious local oncologists, physicians, MBC survivors and a panel discussion.
The Annual Metastatic Conference has been thoughtfully planned by a small committee including women living with metastatic breast cancer. The Planning Committee designed the agenda to provide conference participants with an opportunity to:
(1) Learn about scientific breakthroughs and emerging treatment options
(2) Discover different ways to improve quality of life on a daily basis
(3) Gain support and build community.
The conference is geared towards people living with metastatic breast cancer but is open to breast cancer patients of all stages.
Thanks to a generous donor, we have travel stipends available for attendees travelling further than 60 miles from Jackson. To apply for a travel stipend, please email email@example.com or call 601-932-3999. Stipend request are due by June 15, 2019.
For sponsorship opportunities download our 2019 MBC Sponsorship Packet.
For more information or to register please visit www.komenmemphisms.org or call 601-932-3999.
Keynote Speaker: Dr. Danny Welch, Ph.D., University of Kansas
Danny R. Welch, Ph.D. is a cancer biologist whose laboratory has discovered eight of the 30 known metastasis suppressor genes. His laboratory has also recently discovered how some of those metastasis suppressors function and is designing therapies to take advantage of their mechanisms of action. His is author of more than 200 peer-reviewed publications and more than 20 book chapters. He is also co-editor of the textbook Cancer Metastasis. Welch is currently Professor of Cancer Biology but also has appointments as Professor of Pathology and Professor of Molecular & Integrative Physiology. He is currently a Komen Scholar and Past-President of the Cancer Biology Training Consortium.
|FRIDAY, JUNE 28 / 8 AM -1 PM / CLYDE MUSE CENTER / PEARL MS